
Patrick M. Fernandes
Examiner (ID: 8787, Phone: (571)272-7706 , Office: P/3736 )
| Most Active Art Unit | 3791 |
| Art Unit(s) | 3736, 3791 |
| Total Applications | 613 |
| Issued Applications | 344 |
| Pending Applications | 74 |
| Abandoned Applications | 222 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14569467
[patent_doc_number] => 20190212340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => AN ELISA-LIKE ASSAY FOR QUANTIFYING ENZYMATIC ACTIVITIES OF MONO-ADP-RIBOSYLTRANSFERASES
[patent_app_type] => utility
[patent_app_number] => 16/336074
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16113
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336074
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/336074 | AN ELISA-LIKE ASSAY FOR QUANTIFYING ENZYMATIC ACTIVITIES OF MONO-ADP-RIBOSYLTRANSFERASES | Sep 26, 2017 | Abandoned |
Array
(
[id] => 15365997
[patent_doc_number] => 20200018763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => METHODS TO ASSESS BINDING AGENT SPECIFICITY
[patent_app_type] => utility
[patent_app_number] => 16/335774
[patent_app_country] => US
[patent_app_date] => 2017-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335774
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/335774 | METHODS TO ASSESS BINDING AGENT SPECIFICITY | Sep 25, 2017 | Abandoned |
Array
(
[id] => 17098172
[patent_doc_number] => 20210285963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => Inspection Method Enabling Specific Diagnosis of Pathological State of Diabetic Nephropathy at Early Stage
[patent_app_type] => utility
[patent_app_number] => 16/338729
[patent_app_country] => US
[patent_app_date] => 2017-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338729
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/338729 | Inspection Method Enabling Specific Diagnosis of Pathological State of Diabetic Nephropathy at Early Stage | Sep 25, 2017 | Abandoned |
Array
(
[id] => 17621189
[patent_doc_number] => 11340237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Metabolite biomarkers for diseases associated with the contact activation system
[patent_app_type] => utility
[patent_app_number] => 16/333101
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 2
[patent_no_of_words] => 15778
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333101 | Metabolite biomarkers for diseases associated with the contact activation system | Sep 14, 2017 | Issued |
Array
(
[id] => 14749327
[patent_doc_number] => 20190257837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => Nidogen-1 Fragments Assay
[patent_app_type] => utility
[patent_app_number] => 16/333444
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333444
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333444 | Nidogen-1 Fragments Assay | Sep 12, 2017 | Abandoned |
Array
(
[id] => 16957174
[patent_doc_number] => 11061027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Materials and methods for evaluating and treating cancer
[patent_app_type] => utility
[patent_app_number] => 16/334978
[patent_app_country] => US
[patent_app_date] => 2017-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 13
[patent_no_of_words] => 7921
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16334978
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/334978 | Materials and methods for evaluating and treating cancer | Sep 11, 2017 | Issued |
Array
(
[id] => 14627379
[patent_doc_number] => 20190227057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => MOLECULAR SENSORS
[patent_app_type] => utility
[patent_app_number] => 16/331327
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331327
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/331327 | Molecular sensors | Sep 7, 2017 | Issued |
Array
(
[id] => 15165647
[patent_doc_number] => 10488308
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => Preparation of lipemic plasma or serum samples for the determination of a lipid interference
[patent_app_type] => utility
[patent_app_number] => 15/698618
[patent_app_country] => US
[patent_app_date] => 2017-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5298
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698618
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/698618 | Preparation of lipemic plasma or serum samples for the determination of a lipid interference | Sep 6, 2017 | Issued |
Array
(
[id] => 12794959
[patent_doc_number] => 20180156822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => BIOMARKER FOR CARDIAC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/698554
[patent_app_country] => US
[patent_app_date] => 2017-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698554
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/698554 | BIOMARKER FOR CARDIAC DISORDERS | Sep 6, 2017 | Abandoned |
Array
(
[id] => 13703427
[patent_doc_number] => 20170362668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => CO-BINDER ASSISTED ASSAY METHODS
[patent_app_type] => utility
[patent_app_number] => 15/696953
[patent_app_country] => US
[patent_app_date] => 2017-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15696953
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/696953 | Co-binder assisted assay methods | Sep 5, 2017 | Issued |
Array
(
[id] => 12680905
[patent_doc_number] => 20180118801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AUTOIMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/695812
[patent_app_country] => US
[patent_app_date] => 2017-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15695812
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/695812 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AUTOIMMUNE DISEASES | Sep 4, 2017 | Abandoned |
Array
(
[id] => 12329592
[patent_doc_number] => 09945854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-17
[patent_title] => Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies
[patent_app_type] => utility
[patent_app_number] => 15/693679
[patent_app_country] => US
[patent_app_date] => 2017-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10265
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15693679
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/693679 | Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies | Aug 31, 2017 | Issued |
Array
(
[id] => 13705387
[patent_doc_number] => 20170363648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => Biosensors Engineered from Conditionally Stable Ligand-Binding Domains
[patent_app_type] => utility
[patent_app_number] => 15/692211
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15692211
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/692211 | Biosensors Engineered from Conditionally Stable Ligand-Binding Domains | Aug 30, 2017 | Abandoned |
Array
(
[id] => 14870813
[patent_doc_number] => 20190285648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => NOVEL LIVER CIRRHOSIS OR LIVER FIBROSIS MARKER
[patent_app_type] => utility
[patent_app_number] => 16/328846
[patent_app_country] => US
[patent_app_date] => 2017-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328846
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/328846 | NOVEL LIVER CIRRHOSIS OR LIVER FIBROSIS MARKER | Aug 29, 2017 | Abandoned |
Array
(
[id] => 13691903
[patent_doc_number] => 20170356906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => NUCLEIC ACID APTAMER-BASED DIAGNOSTIC METHODS WITH NOVEL TECHNIQUES FOR SIGNAL ENHANCEMENT
[patent_app_type] => utility
[patent_app_number] => 15/685206
[patent_app_country] => US
[patent_app_date] => 2017-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15685206
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/685206 | NUCLEIC ACID APTAMER-BASED DIAGNOSTIC METHODS WITH NOVEL TECHNIQUES FOR SIGNAL ENHANCEMENT | Aug 23, 2017 | Abandoned |
Array
(
[id] => 17681876
[patent_doc_number] => 11366124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers
[patent_app_type] => utility
[patent_app_number] => 16/326737
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 4
[patent_no_of_words] => 10769
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326737
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326737 | Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers | Aug 22, 2017 | Issued |
Array
(
[id] => 14504473
[patent_doc_number] => 20190195891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => DIAGNOSTIC AND THERAPEUTIC USES OF EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 16/325393
[patent_app_country] => US
[patent_app_date] => 2017-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325393
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/325393 | DIAGNOSTIC AND THERAPEUTIC USES OF EXOSOMES | Aug 17, 2017 | Abandoned |
Array
(
[id] => 18316028
[patent_doc_number] => 11630103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => Product and methods useful for modulating and evaluating immune responses
[patent_app_type] => utility
[patent_app_number] => 16/325807
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 59
[patent_no_of_words] => 153327
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325807
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/325807 | Product and methods useful for modulating and evaluating immune responses | Aug 16, 2017 | Issued |
Array
(
[id] => 13719935
[patent_doc_number] => 20170370922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => FLUIDIC DEVICE, SYSTEM, AND METHOD
[patent_app_type] => utility
[patent_app_number] => 15/679816
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15679816
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/679816 | Fluidic device, system, and method | Aug 16, 2017 | Issued |
Array
(
[id] => 12157345
[patent_doc_number] => 20180028610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'METHODS FOR DETECTING CARDIAC DAMAGE'
[patent_app_type] => utility
[patent_app_number] => 15/674053
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 11163
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/674053 | Methods for detecting cardiac damage | Aug 9, 2017 | Issued |